XML 39 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 26, 2025
Mar. 27, 2024
Cash flows from operating activities:    
Net income $ 326 $ 4,691
Adjustments to reconcile net income to cash flows provided by operating activities:    
Depreciation and amortization 4,107 3,581
Operating (gains), losses and other charges, net 3,911 (327)
Amortization on interest rate swaps, net 259 141
Amortization of deferred financing costs 159 159
Gains on investments (23) (6)
(Gains) losses on early termination of debt and leases (59) 123
Deferred income tax benefit (1,155) (768)
Decrease of tax valuation allowance (8) (26)
Share-based compensation expense 2,785 2,776
Changes in assets and liabilities, excluding acquisitions and dispositions:    
Receivables 7,194 4,011
Inventories (128) 102
Prepaids and other current assets 245 3,208
Other noncurrent assets (2,209) 860
Operating lease assets and liabilities 120 (164)
Accounts payable (356) (11,037)
Other accrued liabilities (9,233) (6,408)
Other noncurrent liabilities (920) (701)
Net cash flows provided by operating activities 5,015 215
Cash flows from investing activities:    
Capital expenditures (9,099) (4,905)
Proceeds from sales of real estate and other assets 1,886 986
Investment purchases 0 (1,500)
Collections on notes receivable 41 171
Issuance of notes receivable 0 (79)
Net cash flows used in investing activities (7,172) (5,327)
Cash flows from financing activities:    
Revolver borrowings 29,900 52,200
Revolver payments (25,200) (46,500)
Repayments of finance leases (309) (370)
Tax withholding on share-based payments (1,000) (1,872)
Purchase of treasury stock (952) (4,774)
Net bank overdrafts (941) 2,699
Net cash flows provided by financing activities 1,498 1,383
Decrease in cash and cash equivalents (659) (3,729)
Cash and cash equivalents at beginning of period 1,698 4,893
Cash and cash equivalents at end of period $ 1,039 $ 1,164